Intravitreal Anti-VEGF Therapy for Macular Radiation Retinopathy: A 10-Year Study

Abstract

Continuous intravitreal anti-VEGF therapy in patients with radiation maculopathy was well-tolerated and preserved vision. In most cases, reductions or resolution of retinal hemorrhages, cotton-wool spots, and retinal edema were noted for up to 10 years.